当前位置:首页 - 行情中心 - 赛升药业(300485) - 财务分析

赛升药业

(300485)

  

流通市值:19.63亿  总市值:34.54亿
流通股本:2.74亿   总股本:4.82亿

赛升药业(300485)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年年度实现净利润-0.77亿元,每股收益-0.14元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年年度最新股东权益338536.76万元,未分配利润178338.02万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年年度最新总资产355184.86万元,负债16648.10万元。

利润表
报告期2024-12-312024-09-302024-06-302024-03-31
营业总收入416,481,789.63322,881,323.81214,836,918.78109,535,330.56
营业总成本391,077,044.74304,126,046.59205,072,867.36103,930,716.38
营业利润-82,973,869.37-121,265,586.49-129,159,971.94-225,039,153.45
利润总额-83,565,994.67-121,501,723.85-129,556,519.06-225,040,253.45
净利润-76,874,137.69-102,205,314.55-108,262,333.29-192,345,921.24
其他综合收益537,717.47-382,426.79221,223.6361,696.26
综合收益总额-76,336,420.22-102,587,741.34-108,041,109.66-192,284,224.98
资产负债表
报告期2024-12-312024-09-302024-06-302024-03-31
流动资产合计1,711,643,897.261,689,442,631.641,380,553,991.011,401,590,451.04
非流动资产合计1,840,204,668.211,828,337,816.352,123,110,163.972,008,659,053.58
资产总计3,551,848,565.473,517,780,447.993,503,664,154.983,410,249,504.62
流动负债合计82,054,311.9683,109,768.0374,334,584.4767,135,525.63
非流动负债合计84,426,698.0580,254,445.6280,366,704.4967,806,873.94
负债合计166,481,010.01163,364,213.65154,701,288.96134,942,399.57
归属于母公司股东权益合计3,357,111,952.593,326,846,743.433,320,498,226.713,245,458,776.88
股东权益合计3,385,367,555.463,354,416,234.343,348,962,866.023,275,307,105.05
负债和股东权益合计3,551,848,565.473,517,780,447.993,503,664,154.983,410,249,504.62
现金流量表
报告期2024-12-312024-09-302024-06-302024-03-31
经营活动现金流入小计447,810,497.61341,818,665.49225,629,269.5114,104,143.09
经营活动现金流出小计311,836,551.41236,357,427.7155,303,702.871,989,356.62
经营活动产生的现金流量净额135,973,946.2105,461,237.7970,325,566.742,114,786.47
投资活动现金流入小计749,432,232.48372,984,859.88281,399,737.66164,833,714.82
投资活动现金流出小计924,789,192.04479,406,883.9390,250,267.01200,914,916.63
投资活动产生的现金流量净额-175,356,959.56-106,422,024.02-108,850,529.35-36,081,201.81
筹资活动现金流入小计4,700,000---
筹资活动现金流出小计10,587,354.3510,587,354.3510,587,354.35-
筹资活动产生的现金流量净额-5,887,354.35-10,587,354.35-10,587,354.35-
汇率变动对现金及现金等价物的影响368,603.89-261,946.79150,663.6342,016.26
现金及现金等价物净增加额-44,901,763.82-11,810,087.37-48,961,653.376,075,600.92
期末现金及现金等价物余额75,262,690.31108,354,366.7671,202,800.76126,240,055.05
TOP↑